Anti-CD45 antibody-drug conjugate - Cimeio Therapeutics
Latest Information Update: 27 Oct 2023
At a glance
- Originator Cimeio Therapeutics
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders; Haematological malignancies